文献速递腹部MRCT

钆塞酸二钠增强肝脏MR成像与多排CT检测异型增生结节和早期肝细胞癌的诊断效能比较

Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.
PubMed 文献 · Radiology · 2017-06-13

本回顾性研究纳入68例经病理证实有异型增生结节、早期肝细胞癌或进展期肝细胞癌的患者及57例对照,比较钆塞酸二钠增强MR与多排CT检测肝硬化相关交界性肝结节的诊断效能。MR检测早期肝细胞癌的敏感度显著高于多排CT,JAFROC读者平均品质因子MR为0.842、多排CT为0.774(P=0.002)。多数早期肝细胞癌和高分化异型增生结节在肝胆期呈低信号,多数早期肝细胞癌被归为LI-RADS 4类。

要点

  • 钆塞酸二钠增强MR检测早期肝细胞癌的敏感度显著高于多排CT。
  • 多数早期肝细胞癌(76.2%)和高分化异型增生结节(82.4%)在肝胆期呈低信号。
  • 多排CT检出早期肝细胞癌中59.4%、MR检出中72.3%被归为LI-RADS 4类。

核心结论

  • 钆塞酸二钠增强MR成像在高风险交界性结节尤其是早期肝细胞癌的检测方面显著优于多排CT。

研究设计与样本

  • 回顾性研究,经伦理委员会批准并豁免知情同意;纳入68例经病理证实有低级别异型增生结节(n=20)、高级别异型增生结节(n=17)、早期肝细胞癌(n=42)或进展期肝细胞癌(n=33)的患者,另纳入57例移植肝无任何异型增生结节或肝细胞癌的患者作为对照;所有患者接受钆塞酸二钠增强MR和多排CT检查;3名放射科医师独立以5分置信度量表评估结节存在并依据影像表现赋予LI-RADS分类;采用JAFROC软件比较各模态病灶检测的诊断准确度。

关键影像表现/征象

  • 多数早期肝细胞癌(76.2%)在肝胆期图像上呈低信号。
  • 多数高级别异型增生结节(82.4%)在肝胆期图像上呈低信号。
  • 多排CT检出的早期肝细胞癌中59.4%、MR检出的早期肝细胞癌中72.3%被归为LI-RADS 4类。
  • 所有读者中,MR较之多排CT额外识别出30个LI-RADS 4类早期肝细胞癌。

诊断标准与关键数值

  • MR检测早期肝细胞癌的读者敏感度分别为78.6%、71.4%、73.8%,多排CT分别为52.4%、50.0%、50.0%(对应P值分别为0.001、0.011、0.001)。
  • JAFROC读者平均品质因子检测肝细胞结节:多排CT为0.774,MR为0.842(P=0.002)。
  • 结节存在与否采用5分置信度量表评估,并按影像表现赋予LI-RADS分类。

临床应用与阅片要点

  • 阅片时对肝硬化患者应关注肝胆期低信号结节,因多数早期肝细胞癌和高分化异型增生结节呈低信号。
  • 报告时可结合LI-RADS分类,注意MR较CT能额外识别更多LI-RADS 4类早期肝细胞癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare the diagnostic performance of gadoxetic acid-enhanced liver magnetic resonance (MR) imaging with that of contrast material-enhanced multidetector computed tomography (CT) in the detection of borderline hepatocellular nodules in patients with liver cirrhosis and to determine the Liver Imaging Reporting and Data System (LI-RADS) categories of these detected nodules. Materials and Methods The institutional review board approved this retrospective study and waived the informed consent requirement. Sixty-eight patients with pathologically proven dysplastic nodules (DNs) (low-grade DNs, n = 20; high-grade DNs, n = 17), early hepatocellular carcinomas (HCCs) (n = 42), or progressed HCCs (n = 33) underwent gadoxetic acid-enhanced MR imaging and multidetector CT. An additional 57 patients without any DNs or HCCs in the explanted livers were included as control subjects. Three radiologists independently graded the presence of liver nodules on a five-point confidence scale and assigned LI-RADS categories by using imaging findings. Jackknife alternative free-response receiver operating characteristics (JAFROC) software was used to compare the diagnostic accuracy of each modality in lesion detection. Results Reader-averaged figures of merit estimated with JAFROC software to detect hepatocellular nodules were 0.774 for multidetector CT and 0.842 for MR imaging (P = .002). Readers had significantly higher detection sensitivity for early HCCs with MR imaging than with multidetector CT (78.6% vs 52.4% [P = .001], 71.4% vs 50.0% [P = .011], and 73.8% vs 50.0% [P = .001], respectively). A high proportion of overall detected early HCCs at multidetector CT (59.4%) and MR imaging (72.3%) were categorized as LI-RADS category 4. Most early HCCs (76.2%) and high-grade DNs (82.4%) demonstrated hypointensity on hepatobiliary phase images. In total, 30 more LI-RADS category 4 early HCCs were identified with MR imaging than with multidetector CT across all readers. Conclusion Gadoxetic acid-enhanced MR imaging performed significantly better in the detection of high-risk borderline nodules, especially early HCCs, than did multidetector CT. © RSNA, 2017 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Kim BR, Lee JM, Lee DH, et al. Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma. Radiology. 2017. PMID: 28609205. doi:10.1148/radiol.2017162080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。